©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2793-2798
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Table 1 Baseline characteristics of 150 chronically infected hepatitis C virus patients with sustained virological response
| Patients | 150 |
| Gender | |
| Male | 100 |
| Female | 50 |
| Patients with histological assessment[20] | 103 |
| Mild hepatitis (G0-G4) | 52 |
| Moderate hepatitis (G5-G9) | 44 |
| Severe hepatitis (G10-G18) | 5 |
| Staging S0-S1 | 44 |
| Staging S2 | 25 |
| Staging S3 | 10 |
| Staging S4-S5 | 9 |
| Cirrhosis S6 | 2 |
| Genotype | |
| 1a | 14 |
| 1b | 75 |
| 2 | 54 |
| 3 | 5 |
| 4 | 2 |
| Comorbidity | |
| Cardiovascular diseases | 13 |
| Thyroid diseases | 7 |
| Crohn’s disease | 1 |
| GERD | 2 |
| Diabetes mellitus type 2 | 2 |
| HBV co-infection | 2 |
- Citation: Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N. Sustained virological response: A milestone in the treatment of chronic hepatitis C. World J Gastroenterol 2013; 19(18): 2793-2798
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2793